A. muciniphila has been reported to increase anti-tumor responses during anti-programmed cell death protein 1 (PD-1) immunotherapy [70], improve metabolic status and clinical outcomes after a dietary intervention in overweight/obese adults [71] and have protective effects in diet-induced obesity [72,73]. This evidence concerns the gene PDCD1 and obesity due to melanocortin 4 receptor deficiency.